Literature DB >> 9864695

[Chronic bilateral subdural hematomas].

G Penchet1, H Loiseau, J P Castel.   

Abstract

BACKGROUND AND
PURPOSE: Are chronic bilateral subdural hematomas different from unilateral forms in terms of delay of diagnosis, clinical presentation and post-operative recovery or recurrence?
METHODS: Etiological, clinical, and radiological aspects and management outcome of bilateral chronic subdural hematomas consecutively managed from 1990 to 1995 were retrospectively analyzed and compared with unilateral forms managed in the same neurosurgical unit during the same period of time.
RESULTS: There were 236 cases. Bilateral subdural hematomas occurred in 41 patients (17.4%). A good outcome was obtained in 97.5% of the cases and morbidity was 14.6%. The differences significantly observed between unilateral and bilateral subdural hematomas were duration of the prediagnostic period, pneumatoceles and recurrence rates (12%). Recurrences were all observed during the first postoperative month and treated with the same initial standardized procedure. The rate of infection or epileptic seizures was low.
CONCLUSIONS: There are few limited differences between uni- and bilateral chronic subdural hematomas. In the latter, a possible correlation between the duration of prediagnostic period and an increased rate of recurrence could be explained by poorer cerebral reexpansion. The overall prognosis of bilateral hematomas is comparable with that observed in unilateral forms. A simple and routinely used burr hole procedure either under local or general anesthesia associated with closed drainage is a safe surgical procedure for either bilateral or unilateral forms and can be performed in all the cases including recurrences. Systematic antiepileptic drugs or antibiotherapy are unnecessary in the medical management of chronic subdural hematomas. One late delayed postoperative clinical control seems to be sufficient.

Entities:  

Mesh:

Year:  1998        PMID: 9864695

Source DB:  PubMed          Journal:  Neurochirurgie        ISSN: 0028-3770            Impact factor:   1.553


  6 in total

Review 1.  Management of Subdural Hematomas: Part II. Surgical Management of Subdural Hematomas.

Authors:  Elena I Fomchenko; Emily J Gilmore; Charles C Matouk; Jason L Gerrard; Kevin N Sheth
Journal:  Curr Treat Options Neurol       Date:  2018-07-18       Impact factor: 3.598

2.  Chronic Subdural Hematomas: Comparison between Unilateral and Bilateral Involvement.

Authors:  Hyun Seok Park; Eun Suk Park; Jun Bum Park; Soon Chan Kwon; In Uk Lyo; Min-Ho Kim; Hong Bo Sim
Journal:  Korean J Neurotrauma       Date:  2014-10-31

3.  Clinical Characteristics of Bilateral versus Unilateral Chronic Subdural Hematoma.

Authors:  Jungjun Lee; Jae Hyo Park
Journal:  Korean J Neurotrauma       Date:  2014-10-31

4.  Bilateral Chronic Subdural Nontraumatic Hematoma in a Woman Affected by AL Amyloidosis.

Authors:  M Luongo; M Grassi; U Godano
Journal:  J Neurol Surg Rep       Date:  2015-06-26

5.  Atorvastatin May Attenuate Recurrence of Chronic Subdural Hematoma.

Authors:  Hua Liu; Zhengxiang Luo; Zhongkun Liu; Jian Yang; Shifeng Kan
Journal:  Front Neurosci       Date:  2016-06-28       Impact factor: 4.677

6.  Acute on Chronic Bilateral Subdural Hematoma in a Woman with a Remote History of Previous Subdural Hematoma Managed by Trephination: A Case Report.

Authors:  Mitesh Karn; Sapana Yonghang
Journal:  JNMA J Nepal Med Assoc       Date:  2020-07-31       Impact factor: 0.406

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.